AMETEK, Inc. (NYSE:AME) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ET

Company Participants

Kevin Coleman - Vice President-Investor Relations & Treasurer
Dave Zapico - Chairman & Chief Executive Officer
Dalip Puri - Executive Vice President & Chief Financial Officer

Conference Call Participants

Matt Summerville - D.A. Davidson
Deane Dray - RBC Capital Markets
Jeff Sprague - Vertical Research Partners
Rob Wertheimer - Melius Research
Scott Graham - Seaport Research Partners
Brett Linzey - Mizuho
Nigel Coe - Wolfe Research
Christopher Glynn - Oppenheimer
Andrew Obin - Bank of America
Joe Giordano - TD Cowen
Steve Barger - KBCM

Operator

Hello, and welcome to the AMETEK Third Quarter 2024 Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.

It is now my pleasure to introduce, Vice President of Investor Relations and Treasurer, Kevin Coleman.

Kevin Coleman

Thank you, Andrew. Good morning and thank you for joining us for AMETEK's Third Quarter 2024 Earnings Conference Call. With me today are Dave Zapico, Chairman and Chief Executive Officer; and Dalip Puri, Executive Vice President and Chief Financial Officer.

During the course of today's call, we will be making forward-looking statements which are subject to change based on various risk factors and uncertainties that may cause actual results to differ significantly from expectations. A detailed discussion of the risks and uncertainties that may affect our future results is contained in AMETEK's filings with the SEC. AMETEK disclaims any intention or obligation to update or revise any forward-looking statements.

Any references made on this call to 2023 or 2024 results or to 2024 guidance will be on an adjusted basis excluding after tax acquisition-related intangible amortization and excluding a pretax of $29.2 million or $0.10 per diluted share charge in the first quarter of 2024 for integration costs related to the Paragon Medical acquisition. Reconciliations between GAAP and adjusted measures can be found in our press release and on the Investors section of our website. We'll begin today's call with prepared remarks and then open it up for questions.

I'll now turn the meeting to Dave.

Dave Zapico

Thank you, Kevin and good morning everyone. AMETEK delivered strong results in the third quarter. Our business has executed extremely well, resulted in earnings per share above our expectations, solid margin performance, outstanding cash flow conversion and double-digit growth in overall orders with positive growth in organic orders.